Maxiphen DM by is a Otc medication manufactured, distributed, or labeled by MCR American Pharmaceuticals, Inc., TG United Inc. Drug facts, warnings, and ingredients follow.
temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other respiratory allergies:
Do not exceed recommended dosage.
Adults and children 12 years of age and over: | 1 tablet by mouth every 4 hours, not to exceed 6 tablets in 24 hours, or as directed by a doctor |
Children 6 to under 12 years of age: | 1/2 tablet by mouth every 4 hours, not to exceed 3 tablets in 24 hours, or as directed by a doctor |
NDC: 58605-0423-01
100 tablets
Maxiphen DM
Antitussive Expectorant Nasal Decongestant
Each immediate-release tablet contains: | |
Dextromethorphan HBr | 20 mg |
Guaifenesin | 400 mg |
Phenylephrine HCl | 10 mg |
This bottle is not be dispensed to consumer.
Dispense in a tight light-resistant container with
a child-resistant cap.
Store at 59°-86°F (15°-30°C) [see USP
Controlled Room Temperature]
Tamper evident by foil seal under cap.
Do not use if foil seal is broken or missing.
MCR American
MAXIPHEN DM
guaifenesin, phenylephrine hydrochloride, and dextromethorphan hydrobromide tablet |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - MCR American Pharmaceuticals, Inc. (783383011) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
MCR American Pharmaceuticals, Inc. | 783383011 | MANUFACTURE |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
TG United Inc | 172837085 | MANUFACTURE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
MAXIPHEN DM 78330862 2953702 Dead/Cancelled |
AMBI Pharmaceuticals, Inc. 2003-11-20 |